Reports for PHARMASCIENCE INC
Formerly known as PENDOPHARM DIVISION OF PHARMASCIENCE INC
Company Name
PHARMASCIENCE INC
Shortage reports
Actual shortage:
53 (4%)
Anticipated shortage:
1 (0%)
Avoided shortage:
37 (3%)
Resolved:
1283 (93%)
1374
Discontinuation Reports
To be discontinued:
2 (1%)
Discontinued:
287 (99%)
Reversed:
2 (1%)
291
211 (13%)
10 (18%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| PMS-URSODIOL C | 250MG | TABLET | Resolved | 2018-08-31 | 2019-02-08 | 59653 |
| PMS-URSODIOL C | 250MG | TABLET | Resolved | 2018-08-31 | 2019-02-08 | 59648 |
| PMS-URSODIOL C | 500MG | TABLET | Resolved | 2024-11-29 | 2024-12-20 | 244166 |
| PMS-URSODIOL C | 500MG | TABLET | Resolved | 2017-07-25 | 2017-10-26 | 17103 |
| PMS-URSODIOL C | 250MG | TABLET | Resolved | 2017-07-25 | 2018-05-05 | 17100 |
| PMS-VALACYCLOVIR | 1000MG | TABLET | Resolved | 2023-07-10 | 2023-12-22 | 198027 |
| PMS-VALACYCLOVIR | 500MG | TABLET | Resolved | 2017-04-20 | 2017-10-11 | 7532 |
| PMS-VALACYCLOVIR | 500MG | TABLET | Resolved | 2024-03-15 | 2024-09-12 | 222390 |
| PMS-VALACYCLOVIR | 1000MG | TABLET | Resolved | 2022-01-27 | 2022-02-07 | 153643 |
| PMS-VALACYCLOVIR | 1000MG | TABLET | Resolved | 2022-01-27 | 2022-02-07 | 153640 |
| PMS-VALACYCLOVIR | 500MG | TABLET | Resolved | 2019-03-04 | 2019-11-15 | 77520 |
| PMS-VALACYCLOVIR | 1000MG | TABLET | Resolved | 2017-09-19 | 2017-12-14 | 22824 |
| PMS-VALACYCLOVIR | 1000MG | TABLET | Resolved | 2024-03-15 | 2024-11-27 | 222393 |
| PMS-VALACYCLOVIR | 1000MG | TABLET | Resolved | 2017-05-18 | 2017-06-16 | 10686 |
| PMS-VALACYCLOVIR | 1000MG | TABLET | Resolved | 2017-05-04 | 2017-07-07 | 8967 |
| PMS-VALACYCLOVIR | 500MG | TABLET | Avoided shortage | 2018-02-22 | 2018-05-04 | 40614 |
| PMS-VALPROIC ACID | 250MG | CAPSULE | Resolved | 2022-09-30 | 2023-05-04 | 170584 |
| PMS-VALPROIC ACID | 250MG | CAPSULE | Actual shortage | 2025-03-17 | 2026-03-11 | 252745 |
| PMS-VALPROIC ACID | 250MG | CAPSULE | Resolved | 2017-09-08 | 2018-04-19 | 21734 |
| PMS-VALPROIC ACID E.C. | 500MG | CAPSULE (ENTERIC-COATED) | Resolved | 2017-03-13 | 2017-03-31 | 1979 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| AC&C TABLETS | 375MG 8MG 15MG | TABLET | Discontinued | 2017-03-31 | 2017-03-31 | 4993 |
| AC&C TABLETS | 375MG 8MG 15MG | TABLET | Discontinued | 2017-03-31 | 2017-03-31 | 4990 |
| AC&C TABLETS | 375MG 8MG 15MG | TABLET | Discontinued | 2017-04-07 | 2017-04-07 | 6031 |
| AC&C TABLETS | 375MG 8MG 15MG | TABLET | Discontinued | 2017-04-07 | 2017-04-07 | 6035 |
| ACET CODEINE 30 | 300MG 30MG | TABLET | Discontinued | 2018-02-22 | 2018-07-23 | 40586 |
| ACET CODEINE 60 | 300MG 60MG | TABLET | Discontinued | 2019-01-16 | 2019-01-17 | 72608 |
| ACETAMINOPHEN, CAFFEINE & CODEINE | 300MG 8MG 15MG | TABLET | Discontinued | 2017-10-12 | 2017-10-13 | 25692 |
| ACETAMINOPHEN, CAFFEINE & CODEINE | 8MG 15MG 300MG | TABLET | Discontinued | 2020-06-15 | 2021-10-27 | 117748 |
| ACETAMINOPHEN, CAFFEINE & CODEINE | 300MG 15MG 8MG | TABLET | Discontinued | 2020-06-15 | 2021-10-27 | 117751 |
| ACETAMINOPHEN, CAFFEINE & CODEINE | 300MG 8MG 15MG | TABLET | Discontinued | 2017-10-12 | 2017-10-13 | 25698 |
| ATORVASTATIN | 40MG | TABLET | Discontinued | 2021-04-23 | 2021-04-23 | 137998 |
| ATORVASTATIN | 20MG | TABLET | Discontinued | 2020-07-23 | 2020-07-23 | 120976 |
| ATORVASTATIN | 40MG | TABLET | Discontinued | 2021-04-23 | 2021-04-23 | 137995 |
| ATORVASTATIN | 10MG | TABLET | Discontinued | 2021-04-23 | 2021-04-23 | 137982 |
| ATORVASTATIN | 10MG | TABLET | Discontinued | 2021-04-23 | 2021-04-23 | 137986 |
| ATORVASTATIN | 20MG | TABLET | Discontinued | 2021-04-23 | 2021-04-23 | 137989 |
| ATORVASTATIN | 20MG | TABLET | Discontinued | 2021-04-23 | 2021-04-23 | 137992 |
| ATORVASTATIN | 80MG | TABLET | Discontinued | 2021-04-23 | 2021-04-23 | 138001 |
| CHARCODOTE SUSP 200MG/ML | 200MG | SUSPENSION | Discontinued | 2020-06-16 | 2020-06-16 | 118017 |
| EGOZINC-HC | 0.5% 0.5% | OINTMENT | Discontinued | 2018-01-26 | 2018-01-26 | 37263 |